TDM-812

N/A

Report date: 2023/07/24 15:33:24
NME

Base Information

Drug NameTDM-812
Drug Alias NameTDM-812
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionRNA interferenceDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2 inhibitors
TargetsDolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 2
Therapy Area/IndicationsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Cancer Center3-D Matrix Medical Technology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNational Cancer Center
Active IndicationsN/A
Inactive IndicationsBreast Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A